文献速递细菌感染、耐药与抗菌药物医院感染防控

FDG-PET/CT整合入金黄色葡萄球菌菌血症诊断流程:前瞻性干预性匹配队列研究

Integration of FDG-PET/CT in the Diagnostic Workup for Staphylococcus aureus Bacteremia: A Prospective Interventional Matched-cohort Study.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该前瞻性匹配队列研究将149例金黄色葡萄球菌菌血症患者纳入干预组,在诊断后7-14天进行FDG-PET/CT并据此指导治疗,与150例未行FDG-PET/CT的匹配患者比较。结论认为FDG-PET/CT可能通过指导治疗时长和协同干预改善生存。

要点

  • SAB患者诊断后7-14天行FDG-PET/CT可发现隐匿性化脓性并发症。
  • 干预组治疗时长更长且更多焦点控制操作,可能解释生存获益。

核心结论

  • FDG-PET/CT用于SAB患者可能通过指导治疗时长和协同干预改善生存。

研究设计与样本

  • 前瞻性干预性匹配队列研究,干预组149例患者共151次SAB发作,在诊断后7-14天行FDG-PET/CT并据此指导治疗。
  • 对照组为150例未行FDG-PET/CT的SAB患者共151次发作,按年龄、Charlson评分、甲氧西林敏感性和生存时长匹配。
  • 主要结局为90天死亡率,通过回归分析控制残余混杂。

主要发现

  • 在无恶性肿瘤的社区获得性感染患者和低风险SAB患者亚组中,死亡率差异仍显著。
  • 干预组治疗时长更长,且执行了更多焦点控制操作。

临床怎么用

  • 对SAB患者可考虑在诊断后7-14天行FDG-PET/CT以排查隐匿性化脓性并发症。
  • FDG-PET/CT结果可用于指导治疗时长和是否需要额外的焦点控制操作。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Staphylococcus aureus bacteremia (SAB) is uniquely characterized by focal pyogenic complications that might not be apparent clinically. We investigated the benefit of adding fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in the workup of patients with SAB. METHODS: In a matched-cohort study patients with SAB (intervention group) were prospectively recruited to undergo FDG-PET/CT 7-14 days after diagnosis. Treatment was directed by FDG-PET/CT findings. Clinical outcomes were compared with a control group of patients with SAB who had not undergone FDG-PET/CT, matched by age, Charlson score, methicillin susceptibility, and survival duration to FDG-PET/CT. The primary outcome was 90-day mortality. Residual confounding was controlled through regression analyses. RESULTS: During the study period 149 patients with 151 separate episodes of SAB underwent FDG-PET/CT and were compared with 150 matched patients with 151 SAB episodes. Patients in the intervention group acquired infections more frequently in the community and had less frequently solid malignancies and more frequently high-risk SAB. Ninety-day mortality in the intervention group was significantly lower than in the control group (21/151 [13.9%] vs 43/151 [28.5%], P = .002). The difference remained significant in a subgroup analysis of patients with community-onset infections without malignancy and among patients with low-risk SAB. Controlling for other risk factors for mortality, FDG-PET/CT performance among all patients was independently associated with lower mortality (OR, .39; 95% CI, .18-.84). Patients in the intervention group had longer duration of treatment and more focus control procedures performed compared with the control group. CONCLUSIONS: FDG-PET/CT in patients with SAB seems to improve survival through guidance of treatment duration and co-interventions.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ghanem-Zoubi N, Kagna O, Abu-Elhija J, et al. Integration of FDG-PET/CT in the Diagnostic Workup for Staphylococcus aureus Bacteremia: A Prospective Interventional Matched-cohort Study. Clin Infect Dis. 2021. PMID: 32639560. doi:10.1093/cid/ciaa929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。